UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 249

Sortiert nach

Effects of different salinities on the osmoregulatory capacity of Mediterranean sticklebacks living in freshwater

Journal of zoology (1987), 2017-12, Vol.303 (4), p.270-280

2017

Volltextzugriff (PDF)

Synovial fluid levels of bradykinin correlate with biochemical markers for cartilage degradation and inflammation in knee osteoarthritis

Osteoarthritis and cartilage, 2013-11, Vol.21 (11), p.1774-1780

2013

Volltextzugriff (PDF)

Bradykinin and B 2 receptor antagonism in rat and human articular chondrocytes

British journal of pharmacology, 2011-02, Vol.162 (3), p.611-622

2011

Volltextzugriff (PDF)

Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B 2 receptor antagonism in human synovial fibroblasts

British journal of pharmacology, 2009-12, Vol.158 (8), p.1996-2004

2009

Volltextzugriff (PDF)

Serum biomarkers detection clusters improve the detection of symptomatic treatment effect in knee osteoarthitis patients: the results of a phase ib/iia study with the b2 receptor antagonist fasitibant

Osteoarthritis and cartilage, 2014-04, Vol.22, p.S63-S63

2014

Volltextzugriff (PDF)

Early development of the digestive tract (pharynx and gut) in the embryos and pre-larvae of the European sea bass Dicentrarchus labrax

Journal of fish biology, 2009-10, Vol.75 (6), p.1302-1322

2009

Volltextzugriff (PDF)

Fasitibant prevents the bradykinin and interleukin 1β synergism on prostaglandin E2 release and cyclooxygenase 2 expression in human fibroblast-like synoviocytes

Naunyn-Schmiedeberg's archives of pharmacology, 2012-08, Vol.385 (8), p.777-786

2012

Volltextzugriff (PDF)

Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B 2 receptor

British journal of pharmacology, 2011-03, Vol.162 (5), p.1202-1212

2011

Volltextzugriff (PDF)

220 BRADYKININ, THROUGH B2 RECEPTORS, ACTIVATES THE RELEASE OF THE CYTOKINE INTERLEUKIN 6, THE CHEMOKINE INTERLEUKIN 8, AND THE METALLOPROTEINASE 3 IN HUMAN KNEE CHONDROCYTES

Osteoarthritis and cartilage, 2010-10, Vol.18, p.S103-S103

2010

Volltextzugriff (PDF)

Bradykinin and B2 receptor antagonism in rat and human articular chondrocytes

British journal of pharmacology, 2011-02, Vol.162 (3), p.611-622

2011

Volltextzugriff (PDF)

Characterization of kinin receptors in human cultured detrusor smooth muscle cells

British journal of pharmacology, 2007-01, Vol.150 (2), p.192-199

2007

Volltextzugriff (PDF)

Comparative antagonist pharmacology at the native mouse bradykinin B 2 receptor: radioligand binding and smooth muscle contractility studies

British journal of pharmacology, 2007-02, Vol.150 (3), p.313-320

2007

Volltextzugriff (PDF)

432 BRADYKININ AND B2 RECEPTOR ANTAGONISM IN HUMAN KNEE SYNOVIOCYTES AND CHONDROCYTES

Osteoarthritis and cartilage, 2008-09, Vol.16, p.S188-S189

2008

Volltextzugriff (PDF)

455 BRADYKININ VIA THE B2 RECEPTOR SYNERGISTICALLY POTENTIATES THE INTERLEUKIN 1 ACTIVATED RELEASE OF PROSTAGLANDIN E2 AND CYCLOOXYGENASE EXPRESSION IN HUMAN-FIBROBLAST LIKE SYNOVIOCYTES

Osteoarthritis and cartilage, 2010, Vol.18, p.S205-S205

2010

Volltextzugriff (PDF)

MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist

British journal of pharmacology, 1998-01, Vol.123 (1), p.81-91

1998

Volltextzugriff (PDF)

Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus

Journal of peptide science, 2007-03, Vol.13 (3), p.164-170

2007

Volltextzugriff (PDF)

Tachykinin receptors and intestinal motility

Canadian journal of physiology and pharmacology, 1997-06, Vol.75 (6), p.696

1997

Volltextzugriff (PDF)

Embryonic development of the sea bass Dicentrarchus labrax

Helgoland marine research, 2012-06, Vol.66 (2), p.199-209

2012

Volltextzugriff (PDF)

Pharmacological profile of the novel mammalian tachykinin, hemokinin 1

British journal of pharmacology, 2002-01, Vol.135 (1), p.266-274

2002

Volltextzugriff (PDF)

220 BRADYKININ, THROUGH B 2 RECEPTORS, ACTIVATES THE RELEASE OF THE CYTOKINE INTERLEUKIN 6, THE CHEMOKINE INTERLEUKIN 8, AND THE METALLOPROTEINASE 3 IN HUMAN KNEE CHONDROCYTES

Osteoarthritis and cartilage, 2010, Vol.18, p.S103-S103

2010

Volltextzugriff (PDF)

Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B2 receptor

British journal of pharmacology, 2011-03, Vol.162 (5), p.1202-1212

2011

Volltextzugriff (PDF)

MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B 2 receptor. In vitro pharmacology and molecular characterization

European journal of pharmacology, 2005-12, Vol.528 (1), p.7-16

2005

Volltextzugriff (PDF)

Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts

British journal of pharmacology, 2009-12, Vol.158 (8), p.1996-2004

2009

Volltextzugriff (PDF)

Characterization of [3H]MEN 11420, a novel glycosylated peptide antagonist radioligand of the tachykinin NK2 receptor

Biochemical and biophysical research communications, 1998-07, Vol.248 (1), p.78-82

1998

Volltextzugriff (PDF)

Differential effects of BQ‐123 against endothelin‐1 and endothelin‐3 on the rat vas deferens: evidence for an atypical endothelin receptor

British journal of pharmacology, 1993-07, Vol.109 (3), p.736-738

1993

Volltextzugriff (PDF)

1 – 25 von 249

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(195)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(125)
Science & Technology
(124)
Life Sciences & Biomedicine
(110)
Female
(73)
Male
(65)
Adult
(50)
Middle Aged
(50)
Biological And Medical Sciences
(44)
Aged
(34)
Animals
(34)
Pharmacology & Pharmacy
(33)
Medical Sciences
(32)
Pharmacology. Drug Treatments
(19)
Rats
(16)
Fundamental And Applied Biological Sciences. Psychology
(14)
Pathology
(14)
Surgery
(14)
Italy
(13)
Icatibant
(12)
Physical Sciences
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effects of different salinities on the osmoregulatory capacity of Mediterranean sticklebacks living in freshwater

Synovial fluid levels of bradykinin correlate with biochemical markers for cartilage degradation and inflammation in knee osteoarthritis

Bradykinin and B 2 receptor antagonism in rat and human articular chondrocytes

Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B 2 receptor antagonism in human synovial fibroblasts

Serum biomarkers detection clusters improve the detection of symptomatic treatment effect in knee osteoarthitis patients: the results of a phase ib/iia study with the b2 receptor antagonist fasitibant

Early development of the digestive tract (pharynx and gut) in the embryos and pre-larvae of the European sea bass Dicentrarchus labrax

Fasitibant prevents the bradykinin and interleukin 1β synergism on prostaglandin E2 release and cyclooxygenase 2 expression in human fibroblast-like synoviocytes

Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B 2 receptor

220 BRADYKININ, THROUGH B2 RECEPTORS, ACTIVATES THE RELEASE OF THE CYTOKINE INTERLEUKIN 6, THE CHEMOKINE INTERLEUKIN 8, AND THE METALLOPROTEINASE 3 IN HUMAN KNEE CHONDROCYTES

Bradykinin and B2 receptor antagonism in rat and human articular chondrocytes

Characterization of kinin receptors in human cultured detrusor smooth muscle cells

Comparative antagonist pharmacology at the native mouse bradykinin B 2 receptor: radioligand binding and smooth muscle contractility studies

432 BRADYKININ AND B2 RECEPTOR ANTAGONISM IN HUMAN KNEE SYNOVIOCYTES AND CHONDROCYTES

455 BRADYKININ VIA THE B2 RECEPTOR SYNERGISTICALLY POTENTIATES THE INTERLEUKIN 1 ACTIVATED RELEASE OF PROSTAGLANDIN E2 AND CYCLOOXYGENASE EXPRESSION IN HUMAN-FIBROBLAST LIKE SYNOVIOCYTES

MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist

Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus

Tachykinin receptors and intestinal motility

Embryonic development of the sea bass Dicentrarchus labrax

Pharmacological profile of the novel mammalian tachykinin, hemokinin 1

220 BRADYKININ, THROUGH B 2 RECEPTORS, ACTIVATES THE RELEASE OF THE CYTOKINE INTERLEUKIN 6, THE CHEMOKINE INTERLEUKIN 8, AND THE METALLOPROTEINASE 3 IN HUMAN KNEE CHONDROCYTES

Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B2 receptor

MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B 2 receptor. In vitro pharmacology and molecular characterization

Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts

Characterization of [3H]MEN 11420, a novel glycosylated peptide antagonist radioligand of the tachykinin NK2 receptor

Differential effects of BQ‐123 against endothelin‐1 and endothelin‐3 on the rat vas deferens: evidence for an atypical endothelin receptor

Suchergebnisse filtern